DNDN
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
CUSIP: 24823Q107HealthcareUS1 holder
Total Value
$7.28M
Total Shares
2.43M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Miller Value Partners
$7.28M2.43M sharesUnchanged